Involved‐field high‐dose chemoradiotherapy with respiratory motion management for esophageal squamous cell carcinoma
Involved-field high-dose CRT with respiratory motion management may be a feasible treatment option for ESCC. However, a comprehensive assessment of esophageal fistula risk is required to identify suitable candidates.
Authors
- Hidekazu Suzuki
- Hikaru Nemoto (ORCID: https://orcid.org/0000-0001-6540-2906)
- Masahide Saito (ORCID: https://orcid.org/0000-0002-8636-4045)
- Hiroshi Onishi (ORCID: https://orcid.org/0000-0002-3512-1166)
- Takafumi Komiyama (ORCID: https://orcid.org/0000-0003-1123-4585)
- Masaki Matsuda (ORCID: https://orcid.org/0009-0003-2694-1829)
- Naoki Sano (ORCID: https://orcid.org/0009-0007-9058-4431)
- Shinichi Aoki
- T. Akita
- Kan Marino (ORCID: https://orcid.org/0000-0001-5230-2041)
Institutions
- University of Yamanashi (JP)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1111/1759-7714.15468
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.57